Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Europe
Europe
Intercept, awaiting needed trial data, pulls its NASH drug application in Europe
BioPharma Dive
Fri, 12/10/21 - 12:00 am
Intercept Pharma
NASH
Europe
obeticholic acid
Science, talent, money: Eir raises $138M VC fund to fill gap in Nordic life science scene
Fierce Biotech
Thu, 12/9/21 - 10:34 am
Eir
funding
Nordic
venture capital
Sweden
Denmark
Europe
Merck KGaA's venture arm is ready to make new investments, raising more than $675M to get things going
Endpoints
Wed, 12/8/21 - 10:41 am
Merck KGaA
venture capital
M Ventures
Europe
Roche’s Actemra/RoActemra approved for treatment of severe COVID-19 in the EU
Biopharma Reporter
Tue, 12/7/21 - 11:04 am
Roche
Actemra
RoActemra
COVID-19
Europe
AI-based drug discovery firm BenevolentAI cuts SPAC deal
Pharmaforum
Mon, 12/6/21 - 11:41 pm
drug discovery
artificial intelligence
BenevolentAI
SPACs
Europe
AbbVie seeks EMA approval for risankizumab (Skyrizi) to treat moderate to severe Crohn’s disease
Pharmaceutical Business Review
Wed, 12/1/21 - 10:22 am
AbbVie
Europe
EMA
Skyrizi
Crohn’s disease
EU steers clear of Aduhelm as a bigger headache threatens
EP Vantage
Thu, 11/18/21 - 10:33 am
Europe
Biogen
Aduhelm
CHMP
Alzheimer's disease
Medicare
Ahead of expected EU objections, Illumina defends Grail acquisition
Endpoints
Wed, 11/17/21 - 11:45 pm
Illumina
Grail
M&A
Europe
Biogen’s Aduhelm, already battling US skepticism, faces likely European rejection
Fierce Pharma
Wed, 11/17/21 - 10:53 am
Biogen
Europe
Aduhelm
Alzheimer's disease
EU decision on Novavax COVID-19 shot could come 'within weeks'
Yahoo/Reuters
Wed, 11/17/21 - 10:25 am
Novavax
Europe
COVID-19
vaccines
Nuvaxovid
Novo Nordisk nears EU approval of obesity drug Wegovy
Pharmaforum
Fri, 11/12/21 - 10:34 am
Novo Nordisk
Wegovy
obesity
Europe
Lilly pulls COVID-19 treatment from EU review while U.S. stocks up
Reuters
Wed, 11/3/21 - 11:46 pm
Eli Lilly
antibodies
COVID-19
Europe
A Pfizer Drug Moves Closer to Approval in Another Important Indication
Motley Fool
Wed, 11/3/21 - 10:38 am
Cibingo
Pfizer
Europe
eczema
atopic dermatitis
Bristol Myers Squibb Just Got Some Great Regulatory News
Motley Fool
Tue, 11/2/21 - 10:45 am
Bristol Myers Squibb
Zeposia
Europe
ulcerative colitis
Novartis has negotiated Zolgensma access for half of the European SMA population, exec says. How'd it get there?
Fierce Pharma
Fri, 10/22/21 - 12:39 pm
Novartis
Europe
Zolgensma
SMA
spinal muscular atrophy
Bluebird, winding down in Europe, withdraws another rare disease gene therapy
BioPharma Dive
Thu, 10/21/21 - 11:17 pm
Bluebird Bio
gene therapy
Europe
Skysona
cerebral adrenoleukodystrophy
Aceto makes further inroads into biopharma space, buys up A&C Bio Buffer
Biopharma Reporter
Wed, 10/13/21 - 11:01 am
Aceto
A&C Bio Buffer
M&A
drug manufacturing
vaccines
Europe
CureVac Adjusts to Vaccine Demand by Reducing European mRNA Manufacturing Network
BioSpace
Tue, 09/14/21 - 10:39 pm
CureVac
MRNA
Europe
vaccines
drug manufacturing
EMA looks at booster data for Pfizer/BioNTech COVID-19 jab
Pharmaforum
Tue, 09/7/21 - 11:49 am
EMA
Europe
Pfizer
BioNTech
vaccines
COVID-19
boosters
BioMarin stands tall with first approved drug for rare disease that causes dwarfism
MedCity News
Sat, 08/28/21 - 08:57 pm
Biomarin
Europe
achondroplasia
dwarfism
Incyte
MorphoSys
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »